Financiere des Professionnels’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26M Sell
4,556
-129
-3% -$57.2K 0.13% 143
2026
Q1
$2.09M Buy
4,685
+4,060
+650% +$1.89M 0.12% 147
2025
Q4
$283K Buy
+625
New +$269K 0.02% 260

Other funds holding VRTX

Financiere des Professionnels's VRTX Position: Q2 2026 in Review

Financiere des Professionnels reduced its Vertex Pharmaceuticals (VRTX) stake by 2.8% in Q2 2026, selling an estimated $57.2K and leaving 4,556 shares worth $2.26M. The position accounts for 0.13% of the portfolio, ranked #143.

Financiere des Professionnels first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Financiere des Professionnels held 4,556 shares of Vertex Pharmaceuticals worth $2.26M as of Q2 2026.
  • Financiere des Professionnels sold 129 Vertex Pharmaceuticals shares in Q2 2026, an estimated $57.2K.
  • Vertex Pharmaceuticals made up 0.13% of Financiere des Professionnels's portfolio in Q2 2026, its #143 holding.
  • Financiere des Professionnels first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Financiere des Professionnels's 13F filing for Q2 2026, filed 5 Aug 2026.